Total Payments
$1.0M
2024 Payments
$108,327
Companies
66
Transactions
2,724
Medicare Patients
2,339
Medicare Billing
$325,237
Payment Breakdown by Category
Other$884,245 (85.2%)
Travel$66,550 (6.4%)
Food & Beverage$55,829 (5.4%)
Consulting$30,740 (3.0%)
Education$221.44 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $884,245 | 517 | 85.2% |
| Travel and Lodging | $66,550 | 442 | 6.4% |
| Food and Beverage | $55,829 | 1,727 | 5.4% |
| Consulting Fee | $30,740 | 15 | 3.0% |
| Education | $221.44 | 23 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $495,293 | 641 | $0 (2024) |
| Lilly USA, LLC | $167,281 | 463 | $0 (2024) |
| Novo Nordisk Inc | $161,353 | 356 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $66,685 | 158 | $0 (2024) |
| Corcept Therapeutics | $44,843 | 138 | $0 (2024) |
| Amgen Inc. | $40,464 | 131 | $0 (2024) |
| Valeritas, Inc. | $24,558 | 144 | $0 (2019) |
| CeQur Corporation | $16,872 | 8 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $6,319 | 18 | $0 (2024) |
| Zealand Pharma US, Inc. | $1,812 | 90 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $108,327 | 368 | Lilly USA, LLC ($85,568) |
| 2023 | $106,749 | 390 | Lilly USA, LLC ($80,796) |
| 2022 | $96,586 | 335 | Novo Nordisk Inc ($57,149) |
| 2021 | $110,444 | 334 | Novo Nordisk Inc ($68,602) |
| 2020 | $73,476 | 220 | AstraZeneca Pharmaceuticals LP ($35,217) |
| 2019 | $131,713 | 358 | AstraZeneca Pharmaceuticals LP ($75,074) |
| 2018 | $202,567 | 379 | AstraZeneca Pharmaceuticals LP ($166,418) |
| 2017 | $207,722 | 340 | AstraZeneca Pharmaceuticals LP ($152,445) |
All Payment Transactions
2,724 individual payment records from CMS Open Payments — Page 1 of 109
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $145.31 | General |
| Category: Automated insulin delivery system | ||||||
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Automated insulin delivery system | ||||||
| 12/30/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Automated insulin delivery system | ||||||
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Neuromodulation | ||||||
| 12/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Endocrinology | ||||||
| 12/20/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Endocrinology | ||||||
| 12/13/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $1.32 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $5.45 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: ENDOCRINE AGENT | ||||||
| 12/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: LIVER DISEASE | ||||||
| 12/04/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/02/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: Rare Disease | ||||||
| 11/26/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $23.84 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Endocrinology | ||||||
| 11/24/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $7.37 | General |
| Category: Endocrinology | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 652 | 1,695 | $215,488 | $101,704 |
| 2022 | 12 | 603 | 1,324 | $179,828 | $88,739 |
| 2021 | 12 | 538 | 1,222 | $159,878 | $75,457 |
| 2020 | 13 | 546 | 1,225 | $143,364 | $59,337 |
Total Patients
2,339
Total Services
5,466
Medicare Billing
$325,237
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 175 | 323 | $77,580 | $40,524 | 52.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 66 | 517 | $35,156 | $25,797 | 73.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 128 | $24,060 | $12,353 | 51.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 38 | 38 | $11,400 | $5,383 | 47.2% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 15 | 261 | $7,830 | $3,063 | 39.1% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 26 | 28 | $11,200 | $2,868 | 25.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 23 | 45 | $12,015 | $2,796 | 23.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 13 | 58 | $7,540 | $2,286 | 30.3% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 12 | 57 | $6,840 | $2,232 | 32.6% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 36 | 47 | $7,050 | $1,283 | 18.2% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 12 | 12 | $3,300 | $1,089 | 33.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 23 | 23 | $7,360 | $888.26 | 12.1% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2023 | 15 | 15 | $1,440 | $681.65 | 47.3% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 89 | 143 | $2,717 | $459.03 | 16.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 142 | 237 | $56,880 | $33,636 | 59.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 60 | 464 | $31,321 | $23,872 | 76.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 228 | $41,040 | $17,041 | 41.5% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2022 | 29 | 58 | $15,486 | $3,951 | 25.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $4,800 | $2,482 | 51.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $5,405 | $2,280 | 42.2% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 12 | 12 | $4,800 | $1,407 | 29.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 29 | 29 | $9,280 | $1,128 | 12.2% |
| G0506 | Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | Office | 2022 | 18 | 18 | $1,728 | $919.96 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 12 | $1,500 | $760.22 | 50.7% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 90 | 202 | $3,838 | $651.15 | 17.0% |
About Dr. Daniel Tung, M.D
Dr. Daniel Tung, M.D is a Specialist healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134224942.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Tung, M.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $108,327 received in 2024. These payments were reported across 2,724 transactions from 66 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($884,245).
As a Medicare-enrolled provider, Tung has provided services to 2,339 Medicare beneficiaries, totaling 5,466 services with total Medicare billing of $325,237. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Diabetes & Metabolism
- Location Houston, TX
- Active Since 09/14/2006
- Last Updated 07/07/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1134224942
Products in Payments
- FARXIGA (Drug) $397,465
- MOUNJARO (Drug) $159,153
- BYDUREON (Drug) $97,397
- RYBELSUS (Drug) $64,025
- Ozempic (Drug) $56,887
- Korlym (Drug) $44,843
- SOLIQUA (Drug) $39,586
- Repatha (Biological) $39,418
- Rybelsus (Drug) $37,884
- V-GO (Device) $25,449
- TOUJEO (Drug) $22,799
- CeQur Simplicity (Device) $16,872
- STRENSIQ (Biological) $6,186
- SOLIQUA 100/33 (Drug) $3,869
- AFREZZA (Drug) $1,334
- JARDIANCE (Drug) $751.72
- Vascepa (Drug) $686.75
- EVENITY (Biological) $674.16
- Kerendia (Drug) $622.13
- TEPEZZA (Drug) $619.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Houston
Dr. James Welsh, Md, MD
Specialist — Payments: $432,652
Specialist $432,652
Dr. Amin Jamal, M.d.,P.a, M.D.,P.A
Specialist — Payments: $264,808
Specialist $264,808
Dr. Rosa Tang, M.d, M.D
Specialist — Payments: $248,234
Specialist $248,234
Dr. Stephen Mahoney, M.d, M.D
Specialist — Payments: $191,264
Specialist $191,264
Dr. Fiaz Zaman, M.d, M.D
Specialist — Payments: $172,386
Specialist $172,386
Dr. Alan Glombicki, M.d, M.D
Specialist — Payments: $142,616
Specialist $142,616